ISIS 702843
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISIS 702843, covering 2019-01-22 to 2019-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers [Phase 1]